Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.43 |
| ▸ | RXRB | P28702 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | TSPO | P30536 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | RAC2 | P15153 | 1/20 | 0.37 |
| ▸ | RAC3 | P60763 | 1/20 | 0.37 |
| ▸ | CDC42 | P60953 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14649151 | 0.97 | KDM4E (0.51) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL14649438 | 0.96 | KDM4E (0.46) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL14649295 | 0.96 | KDM4E (0.50) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL22906534 | 0.94 | KDM4E (0.47) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL14649338 | 0.94 | KDM4E (0.55) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL22906565 | 0.94 | KDM4E (0.55) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL19718703 | 0.94 | KDM4E (0.55) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL16791289 | 0.94 | GPR3 (0.48) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL16791296 | 0.94 | GPR3 (0.48) | KDM4EL3MBTL1ATMGPR3RXRA | |
| SCHEMBL16848791 | 0.94 | GPR3 (0.48) | KDM4EL3MBTL1ATMGPR3RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9266865-B2 | Material for organic electroluminescent element, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| US-9266865-B2 | Material for organic electroluminescent element, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| EP-2555272-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-20130020565-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-20130020565-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130020565-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | PRDM9, CD99, L1CAM | KDM4E 407/4885L3MBTL1 1358/4885ATM 3551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.